OncoCyte Corporation (NYSE: OCX), a developer of novel, non-invasive tests for the early detection of cancer, today announced that Mitch ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE